To investigate the effect of APC and PAR1/PAR2 on AD, a subchronic DNFB-induced CHS model was used to better reflect the chronic pathology of AD and to allow the therapeutic treatment of pre-established skin inflammation [26]. This evidence concerns the gene F2RL1 and Alzheimer disease.